Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
26.69
+0.17 (0.64%)
Dec 5, 2025, 4:00 PM EST - Market closed
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $2.00 billion as of December 5, 2025. Its market cap has increased by 96.34% in one year.
Market Cap
2.00B
Enterprise Value
1.72B
1-Year Change
96.34%
Ranking
Category
Stock Price
$26.69
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $2.00B, an increase of 506.37%. That is a compound annual growth rate of 23.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 2.00B | 98.08% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |